Table 1 Comparison of hospitalized COVID-19 patients from statutory notifications and the LEOSS cohort, Germany 2020
| Â | Hospitalized cases reported to the RKI in Germany 2020 | Hospitalized patients in LEOSS study in Germany |
|---|---|---|
Patients, (n) | 132,943 | 6672 |
Death of hospitalized cases/patients1, % (n) | 21.5% (28642) | 14.3% (957) |
Month of COVID-19 diagnosis, % (n) | ||
 January 2020 | 0.0% (8) | 0.2% (14) |
 February 2020 | 0.0% (35) | 0.4% (29) |
 March 2020 | 7.5% (10,030) | 19.7% (1315) |
 April 2020 | 11.7% (15,551) | 17.0% (1132) |
 May 2020 | 2.3% (3100) | 3.6% (238) |
 June 2020 | 1.0% (1304) | 2.0% (132) |
 July 2020 | 1.0% (1388) | 2.1% (137) |
 August 2020 | 1.3% (1783) | 1.8% (123) |
 September 2020 | 2.0% (2678) | 3.0% (197) |
 October 2020 | 10.5% (13,896) | 13.5% (899) |
 November 2020 | 24.6% (32,674) | 20.1% (1339) |
 December 2020 | 38.0% (50,496) | 16.7% (1117) |
Age (years), % (n) | ||
 0–14 | 1.5% (1945) | 1.0% (68) |
 15–25 | 3.1% (4055) | 2.6% (173) |
 26–35 | 4.8% (6442) | 5.4% (362) |
 36–45 | 5.7% (7613) | 8.0% (531) |
 46–55 | 10.1% (13,417) | 13.7% (915) |
 56–65 | 14.2% (18,848) | 17.6% (1176) |
 66–75 | 16.5% (21,914) | 17.4% (1158) |
 76–85 | 28.8% (38,250) | 24.2% (1616) |
 > 85 | 15.3% (20,370) | 10.1% (673) |
 Missing | 0.1% (89) | – |
Sex, % (n) | ||
 Male | 51.8% (68,919) | 56.6% (3777) |
 Female | 47.9% (63,716) | 43.4% (2895) |
 Diverse | 0.0% (8) | – |
 Missing | 0.2% (300) | – |
Reported comorbidities, % (n) | ||
 Cardiovascular | 24.0% (31,881) | 59.8% (3931/6579) |
 Neurological | 6.9% (9163) | 24.4% (1509/6172) |
 Diabetes mellitus | 10.2% (13,527) | 23.2% (1505/6493) |
 Pulmonary | 7.5% (9956) | 15.3% (986/6460) |
 Cancer | 4.8% (6388) | 14.5% (938/6453) |
 Chronic Liver disease | 1.3% (1780) | 2.1% (134/6417) |
 Chronic Kidney disease | 6.0% (8038) | 15.6% (1004/6420) |